University of Chicago Medical School Introduces Next-Generation Robotic Technology to Fight Early-Stage Lung Cancer

Chicago Medical School is the first U.S. hospital to use new cutting-edge robotic technology for bronchoscopy to improve early detection of lung cancer.

Chicago Medicine conducted the first four successful cases using the Noah Medical Galaxy Robot on May 18, 2023. Each patient was discharged home the same day after the procedure.

The most unique feature of this robot is the X-ray enhanced nodule targeting system. In bronchoscopy, a long tube with a small camera (scope) is guided through the patient’s mouth under anesthesia. A doctor uses a handheld device that resembles a video game controller to navigate the endoscope into the lungs.

D. Kyle Hogarth, M.D., a pulmonologist and expert at the University of Chicago School of Medicine, said that with the help of the robot, the scope could be much more precise and accurate than current first-generation robotic scopes, even in hard-to-reach areas. Said to be able to reach cancerous nodules and lesions in the lungs in places. With advanced bronchoscopy.

“I can’t stress enough how important this new and upgraded technology is,” Hogarth said.

“Even with first-generation robotic scopes, bronchoscopists could miss a nodule. is obtained from,” he said.

This will help someone with an abnormal CT scan determine what the problem is and what to do next.

“This will help someone with an abnormal CT scan figure out what the problem is and what to do next. Make sure.”

New techniques reduce radiation exposure and shorten anesthesia time, resulting in faster recovery. It also provides a faster answer to the question, “Do you have cancer?” question.

“If there’s a way to reduce risk, get better outcomes, and better care for patients, we’re going to do it,” Hogarth said.

This device uses a disposable bronchoscope, a unique feature designed for one-time use. This reduces the chances of infection and disease transmission from cleaned and re-used scopes, a pre-Galaxy US standard.

Hogarth has been a paid consultant to robotics manufacturer Noah Medical since 2018 and owns a stake in the company. The Galaxy Robot System was first used in Australia in March 2023. The US Food and Drug Administration approved its use that month.

In 2018, Chicago Medicine became the second hospital in the nation and the first hospital in the Midwest to install robotic bronchoscopy tools. Since then, Hogarth has worked as a consultant to evolve the company’s navigation and diagnostic capabilities.

Hogarth envisions a future where bronchoscopy includes therapeutics.

“The day is coming when you can see if you have lung cancer during a bronchoscopy. I’m going to treat it from the inside,” he said.

“Imagine being cured of lung cancer, having a bronchoscopy and being discharged from the hospital. is approaching.”

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *